Novel mutations in the glucocerebrosidase gene of Brazilian patients with gaucher disease

JIMD Reports

Volumn 9, Issue , 2013, Pages 7-16

  Siebert, Marina ^a,b   Bock, Hugo ^a,b   Michelin Tirelli, Kristiane ^a   Coelho, Janice C ^a,b   Giugliani, Roberto ^a,b   Saraiva Pereira, Maria Luiza ^a,b  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84885868283     PISSN: 21928304     EISSN: 21928312     Source Type: Book Series    
DOI: 10.1007/8904_2012_174     Document Type: Chapter

References (20)

1. Alfonso P, Cenarro A, Perez-Calvo JI et al (2001) Mutation prevalence among 51 unrelated Spanish patients with Gaucher disease: identification of 11 novel mutations. Blood Cells Mol Dis 27:882–891
2. Alfonso P, Aznarez S, Giralt M et al (2007) Mutation analysis and genotype/phenotype relationships of Gaucher disease patients in Spain. J Hum Genet 52:391–396
3. Amaral O, Pinto E, Fortuna M et al (1996) Type 1 Gaucher disease: identification of N396T and prevalence of glucocerebrosidase mutations in the Portuguese. Hum Mutat 8:280–281
4. Amaral O, Marcao A, Sa Miranda M et al (2000) Gaucher disease: expression and characterization of mild and severe acid beta-glucosidase mutations in Portuguese type 1 patients. Eur J Hum Genet 8:95–102
5. Beutler E, Grabowski GA (2001) Gaucher disease. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease. McGraw-Hill, New York, pp 3635–3668
6. Beutler E, Gelbart T, Scott CR (2005) Hematologically important mutations: Gaucher disease. Blood Cells Mol Dis 35: 355–364
7. den Dunnen JT, Antonarakis SE (2000) Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion. Hum Mutat 15:7–12
8. Grabowski GA, Horowitz M (1997) Gaucher's disease: molecular, genetic and enzymological aspects. Baillieres Clin Haematol 10:635–656
9. Horowitz M, Wilder S, Horowitz Z et al (1989) The human glucocerebrosidase gene and pseudogene: structure and evolution. Genomics 4:87–96
10. Hruska KS, LaMarca ME, Scott CR et al (2008) Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA). Hum Mutat 29:567–583
11. Kumar P, Henikoff S, Ng PC (2009) Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc 4:1073–1082
12. Lesage S, Anheim M, Condroyer C et al (2011) Large-scale screening of the Gaucher’s disease-related glucocerebrosidase gene in Europeans with Parkinson´s disease. Hum Mol Genet 20:202–210
13. Michelin K, Wajner A, de Souza FT et al (2005) Application of a comprehensive protocol for the identification of Gaucher disease in Brazil. Am J Med Genet 136:58–62
14. Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215
15. Ramensky V, Bork P, Sunyaev S (2002) Human non-synonymous SNPs: server and survey. Nucleic Acids Res 30:3894–3900
16. Rozenberg R, Araujo FT, Fox DC et al (2006) High frequency of mutation G377S in Brazilian type 3 Gaucher disease patients. Braz J Med Biol Res 39:1171–1179
17. Sidransky E (2004) Gaucher disease: complexity in a “simple” disorder. Mol Genet Metab 83:6–15
18. Sobreira E, Pires RF, Cizmarik M, Grabowski GA (2007) Phenotypic and genotypic heterogeneity in Gaucher disease type 1: a comparison between Brazil and the rest of the world. Mol Genet Metab 90:81–86
19. Winfield SL, Tayebi N, Martin BM et al (1997) Identification of three additional genes contiguous to the glucocerebrosidase locus on chromosome 1q21: implications for Gaucher disease. Genome Res 7:1020–1026
20. Yue P, Moult J (2006) Identification and analysis of deleterious human SNPs. J Mol Biol 356:1263–1274